Market Research Logo

Denmark Pharmaceuticals and Healthcare Report Q2 2016

Denmark Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Limited by its population size, Denmark has a relatively small pharmaceutical marketcompared to its Western European counterparts. We believe that pharmaceutical market growth willcontinue in 2016 in local currency terms, especially as economic conditions improve. The demand forinnovative medicines and high quality healthcare services will be driven by the country's aging populationand high per capita spending. However, in the long-term a higher pensionable population would putconsiderable strain on government finances, creating the possibility of further cost-containment measurestargeting the healthcare sector.

Headline Expenditure Projections

Pharmaceuticals: DKK21.30bn (USD3.14bn) in 2015 to DKK21.74bn (USD3.12bn) in 2016; +2.1% inlocal currency terms and -0.7% in US dollar terms. Forecast unchanged from last quarter.

Healthcare: DKK201.38bn (USD29.73bn) in 2015 to DKK205.46bn (USD29.50bn) in 2015; +2.0% inlocal currency terms and -0.8% in US dollar terms. Forecast revised downwards slightly from lastquarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Denmark 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Denmark 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Denmark 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Denmark 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Denmark 2012-2020)
Industry Risk/Reward Index
Western Europe Risk/Reward Index
Denmark Risk/Reward Index
Rewards
Risks
Regulatory Review
Pricing Regime
Reimbursement Regime
Table: Expenditure On Reimbursed Medicines (DKKmn)
Market Overview
Healthcare Sector
Table: Healthcare Resources (Denmark 2010-2015)
Table: Healthcare Personnel (Denmark 2010-2015)
Table: Healthcare Activity (Denmark 2010-2015)
Epidemiology
Competitive Landscape
Research-Based Industry
Table: LIF Member Companies
Table: Multinational Market Activity
Demographic Forecast
Table: Population Headline Indicators (Denmark 1990-2025)
Table: Key Population Ratios (Denmark 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Denmark 1990-2025)
Table: Population By Age Group (Denmark 1990-2025)
Table: Population By Age Group % (Denmark 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report